Myelodysplastic syndromes trials in Denmark

In Denmark 10 Also abroad 369

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Where
Aarhus N, Copenhagen Oe, Odense C
People
225 worldwide
Run by
Janssen Cilag International
See details and how to join2026-525234-39-00 · EU 2026-525234-39-00
Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Copenhagen Oe, Odense C
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 1Taking people
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
78 worldwide
Run by
Genmab
See details and how to joinNCT07384715 · EU 2025-523101-15-00
Phase 1/2Taking people
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Where
Copenhagen Oe
Age
16 years and over
People
85 worldwide
Run by
AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00
No phaseTaking people
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
Where
Aalborg, Aarhus, Esbjerg, Herning, Odense, Roskilde, Vejle
Age
18 years and over
People
920
Run by
Christoffer Johansen
See details and how to joinNCT05444348
Phase 2Taking people
NMDSG-14B2
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
200 worldwide
Run by
Karolinska University Hospital
See details and how to join2024-511651-17-00 · EU 2024-511651-17-00
Phase 2Taking people
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
Where
Aarhus N, Copenhagen Oe, Odense C
Age
18 years to 64 years
People
90 worldwide
Run by
Pharmacosmos A/S
See details and how to joinNCT05693909 · EU 2023-507396-21-00
No phaseTaking people
Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions
Where
Copenhagen
Age
18 years and over
People
36
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT06773871
Phase 2Taking people
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Where
Copenhagen Oe
Age
18 years and over
People
40
Run by
Kirsten Grønbæk
See details and how to joinNCT04741945 · EU 2024-518436-37-01
Phase 2Taking people
Combining Active and Passive DNA Hypomethylation
Where
Aalborg, Aarhus, Copenhagen, Odense, Roskilde
Age
18 years and over
People
196 worldwide
Run by
Kirsten Grønbæk
See details and how to joinNCT03999723